New research links diabetes drugs semaglutide and tirzepatide to a higher risk of rare optic nerve damage, raising safety concerns for patients.

New research links diabetes drugs semaglutide and tirzepatide to a higher risk of rare optic nerve damage, raising safety concerns for patients.

A new study by the U.S. Food and Drug Administration (FDA), published in the Annals of Internal Medicine, has raised concerns about a rare but...

A new study by the U.S. Food and Drug Administration (FDA), published in the Annals of Internal Medicine, has raised concerns about a rare but...

With more people turning to popular weight-loss medications, questions about potential side effects are increasing — and some consumers are...

Patients with a diabetes-related eye condition who are male, Black or Hispanic are more likely to miss follow-up appointments after treatment, putting...

Patients with a diabetes-related eye condition who are male, Black or Hispanic are more likely to miss follow-up appointments after treatment, putting...

By now, you have probably heard about the weight-loss benefits of glucagon-like peptide-1 drugs such as Ozempic (semaglutide) and Mounjaro...

By now, you have probably heard about the weight-loss benefits of glucagon-like peptide-1 drugs such as Ozempic (semaglutide) and Mounjaro...

The anti-obesity drug tirzepatide, known as Mounjaro (for diabetes) and Zepbound (for obesity), has been found to reduce breast cancer growth linked...